Published in Fertil Steril on January 08, 2010
The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum. J Pediatr Adolesc Gynecol (2014) 1.41
Nonhuman primate models of polycystic ovary syndrome. Mol Cell Endocrinol (2013) 0.91
Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study. Hum Reprod (2014) 0.89
Anti-müllerian hormone is not associated with cardiometabolic risk factors in adolescent females. PLoS One (2013) 0.87
Involvement of androgens in ovarian health and disease. Mol Hum Reprod (2013) 0.86
Anti-müllerian hormone and its clinical use in pediatrics with special emphasis on disorders of sex development. Int J Endocrinol (2013) 0.85
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev (2016) 0.83
Serum Copeptin, Pentraxin 3, Anti-Mullerian Hormone Levels With Echocardiography and Carotid Artery Intima-Media Thickness in Adolescents With Polycystic Ovary Syndrome. J Clin Med Res (2015) 0.83
Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents. J Pediatr Endocrinol Metab (2014) 0.82
Different diagnostic power of anti-Mullerian hormone in evaluating women with polycystic ovaries with and without hyperandrogenism. J Assist Reprod Genet (2012) 0.82
Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood. Fertil Steril (2013) 0.82
Diagnosis and challenges of polycystic ovary syndrome in adolescence. Semin Reprod Med (2014) 0.79
Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review. Reprod Biol Endocrinol (2015) 0.79
Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol (2016) 0.78
Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progress. Indian J Endocrinol Metab (2015) 0.78
Assessment of Anti-Müllerian Hormone Level in Management of Adolescents with Polycystic Ovary Syndrome. J Clin Res Pediatr Endocrinol (2015) 0.77
Anti-Müllerian Hormone in Obese Adolescent Girls With Polycystic Ovary Syndrome. J Adolesc Health (2016) 0.75
Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results. J Clin Res Pediatr Endocrinol (2016) 0.75
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril (2008) 5.31
Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab (2006) 4.56
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod (2009) 3.74
Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial. Ann Intern Med (2008) 3.25
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril (2011) 2.80
Treatment of periodontal disease during pregnancy: a randomized controlled trial. Obstet Gynecol (2009) 2.62
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab (2010) 2.48
Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ (2003) 2.40
Defining polycystic ovary syndrome. BMJ (2009) 2.32
Stage-based treatment of twin-twin transfusion syndrome. Am J Obstet Gynecol (2003) 2.27
Body surface area and body weight predict total liver volume in Western adults. Liver Transpl (2002) 2.21
Medical treatments for incomplete miscarriage (less than 24 weeks). Cochrane Database Syst Rev (2010) 2.18
Free testosterone levels in umbilical-cord blood predict infant head circumference in females. Dev Med Child Neurol (2010) 2.06
Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome. Med J Aust (2007) 2.03
Biophysical profile with amniotic fluid volume assessments. Obstet Gynecol (2004) 2.01
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update (2010) 1.86
Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin. Clin Chem (2009) 1.82
Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update (2013) 1.81
Community-based screening for Down's Syndrome in the first trimester using ultrasound and maternal serum biochemistry. BJOG (2005) 1.78
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev (2012) 1.76
Advanced abdominal pregnancy: still an occurrence in modern medicine. Aust N Z J Obstet Gynaecol (2005) 1.74
Volume and frequency of breastfeedings and fat content of breast milk throughout the day. Pediatrics (2006) 1.69
Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia. Pediatrics (2005) 1.62
Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol (2004) 1.55
The potential implications of a PCOS diagnosis on a woman's long-term health using data linkage. J Clin Endocrinol Metab (2014) 1.54
Age at menarche: Influences of prenatal and postnatal growth. J Clin Endocrinol Metab (2006) 1.53
Mifepristone and oral, vaginal, or sublingual misoprostol for second-trimester abortion: a randomized controlled trial. Obstet Gynecol (2014) 1.53
Characterization and significance of adhesion and junction-related proteins in mouse ovarian follicles. Biol Reprod (2012) 1.53
Prostaglandins and mechanisms of preterm birth. Reproduction (2002) 1.52
Preterm birth rates in Chinese women in China, Hong Kong and Australia - the price of Westernisation. Aust N Z J Obstet Gynaecol (2011) 1.52
The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review. Breast Cancer Res Treat (2009) 1.52
Predictors of sexual intercourse and rapid-repeat pregnancy among teenage mothers: an Australian prospective longitudinal study. Med J Aust (2010) 1.51
A randomized trial of amnioreduction versus septostomy in the treatment of twin-twin transfusion syndrome. Am J Obstet Gynecol (2005) 1.48
Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev (2011) 1.47
Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril (2008) 1.44
Power Doppler assessment of follicle vascularity at the time of oocyte retrieval in in vitro fertilization cycles. Fertil Steril (2008) 1.44
Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res (2002) 1.42
The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care. Menopause (2010) 1.41
Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reverses the adverse effects of diet-induced obesity on oocyte quality. Endocrinology (2008) 1.41
Obese women exhibit differences in ovarian metabolites, hormones, and gene expression compared with moderate-weight women. J Clin Endocrinol Metab (2009) 1.40
Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control (2003) 1.39
Intrapartum analgesia and its association with post-partum back pain and headache in nulliparous women. Aust N Z J Obstet Gynaecol (2006) 1.38
A randomized, placebo-controlled trial of preoperative oral pregabalin for postoperative pain relief after minor gynecological surgery. Anesth Analg (2007) 1.37
Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg (2002) 1.35
Macrophage contributions to ovarian function. Hum Reprod Update (2004) 1.35
Beta-oxidation is essential for mouse oocyte developmental competence and early embryo development. Biol Reprod (2010) 1.34
Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clin Endocrinol (Oxf) (2007) 1.31
Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study. J Clin Endocrinol Metab (2004) 1.30
Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial. Fertil Steril (2008) 1.30
Influence of acupuncture stimulation on pregnancy rates for women undergoing embryo transfer. Fertil Steril (2006) 1.30
High-fat diet causes lipotoxicity responses in cumulus-oocyte complexes and decreased fertilization rates. Endocrinology (2010) 1.29
The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome. J Clin Endocrinol Metab (2008) 1.29
Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust (2011) 1.23
Obesity and menstrual irregularity: associations with SHBG, testosterone, and insulin. Obesity (Silver Spring) (2009) 1.22
Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev (2011) 1.22
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev (2010) 1.21
Hormonal profile of women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland birth cohort 1966 study. J Clin Endocrinol Metab (2003) 1.21
It's now or never: fertility-related knowledge, decision-making preferences, and treatment intentions in young women with breast cancer--an Australian fertility decision aid collaborative group study. J Clin Oncol (2011) 1.20
Follicle-stimulating hormone affects metaphase I chromosome alignment and increases aneuploidy in mouse oocytes matured in vitro. Biol Reprod (2004) 1.20
Prenatal diagnosis and management of congenital cystic adenomatoid malformation of the lung. Am J Obstet Gynecol (2002) 1.19
Offspring of mothers fed a high fat diet display hepatic cell cycle inhibition and associated changes in gene expression and DNA methylation. PLoS One (2011) 1.19
A review of idiopathic hydramnios and pregnancy outcomes. Obstet Gynecol Surv (2007) 1.16
Preconception lifestyle advice for people with subfertility. Cochrane Database Syst Rev (2010) 1.16
Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries. J Clin Endocrinol Metab (2005) 1.16
Programming and reproductive functioning. Trends Endocrinol Metab (2002) 1.14
The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatr Res (2007) 1.13
Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia. Lancet (2002) 1.11
Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population. Am J Obstet Gynecol (2008) 1.10
Insulin resistance increases the risk of spontaneous abortion after assisted reproduction technology treatment. J Clin Endocrinol Metab (2007) 1.10
The volume of blood for epidural blood patch in obstetrics: a randomized, blinded clinical trial. Anesth Analg (2011) 1.09
Caesarean scar ectopic pregnancy: a single centre case series. Aust N Z J Obstet Gynaecol (2009) 1.09
Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome. Fertil Steril (2009) 1.08
Environment, lifestyle and infertility--an inter-generational issue. Nat Cell Biol (2002) 1.08
Impact of obesity on female fertility and fertility treatment. Womens Health (Lond Engl) (2008) 1.07
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev (2009) 1.06
Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev (2009) 1.06
Knowledge about factors that influence fertility among Australians of reproductive age: a population-based survey. Fertil Steril (2012) 1.05
Impact of intrapartum epidural analgesia on breast-feeding duration. Aust N Z J Obstet Gynaecol (2003) 1.05
Aromatase inhibitors for PCOS: a systematic review and meta-analysis. Hum Reprod Update (2012) 1.04
Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 1.02
Is placenta accreta catching up with us? Aust N Z J Obstet Gynaecol (2004) 1.02
Incidence of spontaneous abortion among pregnancies produced by assisted reproductive technology. Hum Reprod (2004) 1.02
Sex-specific associations between umbilical cord blood testosterone levels and language delay in early childhood. J Child Psychol Psychiatry (2012) 1.02
Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome. Am J Clin Nutr (2006) 1.02
Single embryo transfer reduces the risk of perinatal mortality, a population study. Hum Reprod (2012) 1.01
Maternal undernutrition significantly impacts ovarian follicle number and increases ovarian oxidative stress in adult rat offspring. PLoS One (2010) 1.01
Luteal phase progesterone excretion in ovulatory women with polycystic ovaries. Hum Reprod (2002) 1.00
Fetal head circumference growth in children with specific language impairment. Arch Dis Child (2010) 0.99
Androgens and polycystic ovary syndrome. Curr Opin Endocrinol Diabetes Obes (2009) 0.99
Endometrial resection / ablation techniques for heavy menstrual bleeding. Cochrane Database Syst Rev (2009) 0.98
Increased beta-oxidation and improved oocyte developmental competence in response to l-carnitine during ovarian in vitro follicle development in mice. Biol Reprod (2011) 0.98
Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects. Atherosclerosis (2008) 0.98
C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 0.98
Disordered follicle development in ovaries of prenatally androgenized ewes. J Endocrinol (2007) 0.98